Metformin HCL prices in the Chinese market are back on track in the first half of October 2025 after a slip in September. That September dip was caused by a bit of a surge in domestic production capacity, some exporters getting a bit of a reprieve due to that U.S–China tariff truce getting extended and decline in raw materials prices. Although demand from the pharmaceutical and healthcare sectors kept the market stable, the price of Metformin HCL did take a bit of a tumble for a while. As October rolled around though, importers were back in the market restocking and stable production cycles meeting the steady demand that's coming from downstream. Manufacturers got back up to full capacity post-holiday. Improved purchasing is coming in, there's still a good supply of the raw materials and there's interest from countries in Southeast Asia, the Middle East, and Latin America - all of which are increasing the demand. Analysts anticipated that prices are likely to keep climbing in the second half of October.
